DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe S 2 · Volume 31 · Juli 1998 DOI: 10.1055/s-002-6334

Editorial

61
Gouzoulis-Mayfrank, E.; Sass, H.: Hallucinogenic Drugs in Experimental Psychiatric Research

Original Papers

63
Gouzoulis-Mayfrank, E.; Hermle, L.; Thelen, B.; Sass, H.: History, Rationale and Potential of Human Experimental Hallucinogenic Drug Research in Psychiatry
69
Kovar, K.-A.: Chemistry and Pharmacology of Hallucinogens, Entactogens and Stimulants
73
Geyer, M. A.: Behavioral Studies of Hallucinogenic Drugs in Animals: Implications for Schizophrenia Research
80
Dittrich, A.: The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans
85
Hermle, L.; Gouzoulis-Mayfrank, E.; Spitzer, M.: Blood Flow and Cerebral Laterality in the Mescaline Model of Psychosis
92
Vollenweider, F. X.: Advances and Pathophysiological Models of Hallucinogenic Drug Actions in Humans: A Preamble to Schizophrenia Research
104
Abi-Saab, W. M.; D'Souza, D. C.; Moghaddam, B.; Krystal, J. H.: The NMDA Antagonist Model for Schizophrenia: Promise and Pitfalls
110
Schneider, U.; Leweke, F. M.; Mueller-Vahl, K. R.; Emrich, H. M.: Cannabinoid/Anandamide System and Schizophrenia: Is there Evidence for Association?
114
Gouzoulis-Mayfrank, E.; Schneider, F.; Friedrich, J.; Spitzer, M.; Thelen, B.; Sass, H.: Methodological Issues of Human Experimental Research with Hallucinogens